Several small molecule drugs, including VPA, gemcitabine, superpolyamide hydroxamic acid (SAHA), and temozolomide, have been shown to improve NK cell-mediated cytotoxicity against cancer cells by upregulating NKG2D ligands (13, 17). The gene discussed is KLRK1; the disease is cancer.